MRI In Acute Stroke: Promises and Pitfalls

April 12, 2022
MRI imagining is becoming more available in acute settings; understanding MRI in stroke is critical to staying ahead of the curve.
0 Comments

How Do You Operationalize the Use of the ASPECTS Score and Is It the Poor Man’s CTP?

April 5, 2022
The ASPECTS score has become more widespread in use with the increase in availability of endovascular therapy. This podcast is a must if you care for acute stroke patients. This is an absolute "must-know" topic for anyone who looks at head CT images in strokes.
0 Comments

Ataxia and Dystaxia: How To Examine and Discuss These Disabling Symptoms With Your Patients

March 29, 2022
Ataxia and dystaxia are often missed clinically. But they're important and potentially disabling. Listen to this podcast to learn more and help you identify these high-risk patients.
0 Comments

Posterior Circulation Horror Stories: How To Save the Day and Your Patient

March 22, 2022
Posterior circulation strokes are often devastating. The diagnostics are different and the treatments are evolving. If you care for stroke patients, this podcast is a must.
0 Comments

Confusion vs. Aphasia- So Important and So Challenging at Times!

March 15, 2022
Confusion isn't really a stroke symptom but aphasia clearly is. One is life threatening and the other can often be self limited and benign. Are you sure your neurological exam is up to the task?
0 Comments
RSS
135678910Last
Categories
More Entries

Dec 4

What Was Missing From the NINDS Trial?

Brian Gibler posted on 12/4/2020

Moderator: Jordan Bonomo, MD, FCCM, FNCS
Other Participants: Opeolu Adeoye, MD, MS FACEP, FAHA

The NINDS trial was the seminal study of IV-tPA in the treatment of acute stroke. Yet controversy still exists around the trial methodology and the interpretation of the data. Was anything missing from NINDS? Does it still resonate nearly 25 years later?

Dr. Opeolu (Ope) Adeoye sits down with Dr. Jordan Bonomo and shares his immense expertise in clinical trialing. As a researcher carrying over $30M in research funding, Dr. Adeoye is an internationally recognized stroke trialist and methodologist. In this podcast, he talks about the challenges of the NINDS trial, what was really well done and what could have been different. “Time critical diagnosis” is the term he wields in this exciting and thought provoking podcast.

0 Comments
Please login or register to post comments.